Selasa, 28 Desember 2021

Passage Bio Inc Stock Price

What is wall street's target price for passage bio inc (pasg) stock? Passage bio, a genetic medicines company, is changing the future of monogenic cns disease and transforming the lives of patients and their families.


Mechanical Desk Lamp Lamp Art Lamp Desk Lamp

In the latest trading session, bionano genomics, inc.

Passage bio inc stock price. Monday, february 08, 2021 02:14 pm | investorsobserver analysts analysts who follow passage bio inc ( pasg ) on average expect it to increase 40.44% over the next twelve months. Find the latest passage bio, inc. 25, 2021 at 7:22 a.m.

View daily, weekly or monthly format back to when passage bio, inc. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Passage bio initiated at outperform with $29 target price at raymond james marketwatch.

Get the latest passage bio, inc. (pasg) stock quote, history, news and other vital information to help you with your stock trading and investing. Passage bio started at outperform with $26 stock price target at wedbush.

Compare pasg stock to peers. Passage bio inc nasdaq updated nov 26, 2021 6:01 pm. The average passage bio stock price prediction forecasts a potential downside of n/a from the current pasg share price of $7.51.

(bngo) closed at $5.87, marking a. This suggests a possible upside of. Their forecasts range from $10.00 to $42.00.

On average, they anticipate imara's share price to reach $21.33 in the next twelve months. Passage bio announces inducement award under nasdaq listing rule 5635(c)(4) | iq stock market Pasg passage bio inc — stock price and discussion | stocktwits.

On average, wall street analysts predict that. Passage bio's share price could stay at $31.50 by jul 1, 2022. Passage bio started at outperform with $26 stock price target at wedbush marketwatch.

Pasg investment & stock information. (bngo) stock sinks as market gains: 102 rows discover historical prices for pasg stock on yahoo finance.

Passage bio, a preclinical biotech developing gene therapies for rare cns disorders, raised $216 million by offering an upsized 12 million shares at $18, the high end of the range of $16 to $18.


Bio Pharmaceuticals - Corporate Responsive New Client Redesign Q4 Design Pharma Corporate Bio


Pin On Spinner Fidget


Wonderful Totally Free Soy Candles Quotes Popular So That You Pretty Your Best Department Store Or Possibly I In 2021 Candle Quotes Candle Quotes Funny Coconut Candle


Limited Edition March Colourpop Crushes Best Makeup Products Makeup Set Purple Makeup


Share:

0 komentar:

Posting Komentar

Labels

Blog Archive